LEXURE for Post-Stroke Aphasia
NCT: NCT07570264 · RECRUITING
Brief Summary
This study evaluates the efficacy of digital language rehabilitation using LEXURE for the treatment of post-stroke aphasia. Half of participants will receive structured language training using the LEXURE application, while the other half will receive workbook-based language training as an active comparator.
Frequently Asked Questions
What is LEXURE for Post-Stroke Aphasia?
LEXURE for Post-Stroke Aphasia is a clinical trial registered under NCT07570264. Current status: RECRUITING.
What is the status of NCT07570264?
The current status of NCT07570264 (LEXURE for Post-Stroke Aphasia) is: RECRUITING.
When did LEXURE for Post-Stroke Aphasia start?
LEXURE for Post-Stroke Aphasia started on 2026-04-16.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.